Anaphylactoid reactions to dextran 40 and 70: Reports to the US Food and Drug Administration (FDA)

被引：0
|
作者：
Zinderman, Craig E. [1 ]
Landow, Laurence Landow [1 ]
Wise, Robert P. [1 ]
机构：
[1] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2006年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
246
引用
收藏
页码：S115 / S116
页数：2
相关论文
共 50 条
  • [21] Paxlovid™ Information From US Food & Drug Administration (FDA) and Guidance for AES Members
    Cokley, Jon A.
    Gidal, Barry E.
    Keller, Joy A.
    Vossler, David G.
    EPILEPSY CURRENTS, 2022, 22 (03) : 201 - 204
  • [22] US Food and Drug Administration (FDA) proposes health claim for oatmeal and oat bran
    不详
    NUTRITION REVIEWS, 1996, 54 (02) : 69 - 69
  • [23] US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®)
    Naseer, Shabnam
    Weinstein, Edward A.
    Rubin, Daniel B.
    Suvarna, Kalavati
    Wei, Xiaohui
    Higgins, Karen
    Goodwin, Avery
    Jang, Seong H.
    Iarikov, Dmitri
    Farley, John
    Nambiar, Sumathi
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : E1103 - E1111
  • [24] CAUSES OF ANAPHYLACTOID REACTIONS IN CATTLE AFTER LIPOID DRUG ADMINISTRATION
    TOMAN, M
    KREJCI, J
    PINKA, K
    MENSIK, P
    VETERINARNI MEDICINA, 1992, 37 (08) : 417 - 426
  • [25] US FOOD AND DRUG ADMINISTRATION (FDA) POSTMARKETING REQUIREMENTS AND COMMITMENTS RELATED TO DRUG DISPOSITION IN LACTATION AND PREGNANCY
    Ridge, S.
    Ramamoorthy, A.
    Guinn, D.
    Zineh, I.
    Fletcher, E. Pfuma
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S77 - S77
  • [26] Characterization of Pediatric Reports in the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) from 2010-2020
    Phan, M.
    Cheng, C.
    Dang, V.
    Wu, E.
    Munoz, M.
    DRUG SAFETY, 2021, 44 (12) : 1459 - 1460
  • [27] Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014
    Moore, Thomas J.
    Furberg, Curt D.
    Mattison, Donald R.
    Cohen, Michael R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (06) : 713 - 718
  • [28] US FDA reports new steps in drug safety
    Reactions Weekly, 2007, 1138 (1) : 3 - 3
  • [29] Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA)
    Weaver, Joyce
    La Grenade, Lois
    Kwon, Hyon
    Avigan, Mark
    DERMATOLOGIC THERAPY, 2009, 22 (03) : 204 - 215
  • [30] US Food and Drug Administration Updates
    Sahin, L.
    BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 748 - 748
12345